Cryptococcal meningitis in patients with or without human immunodeficiency virus: Experience in a tertiary hospital

Yonsei Medical Journal

Volumn 52, Issue 3, 2011, Pages 482-487

  Lee, Su Jin ^a   Choi, Hee Kyoung ^a   Son, Jungmin ^a   Kim, Kye Hyung ^a   Lee, Sun Hee ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

Cryptococcal meningitis; HIV; Neurologic symptom

Indexed keywords

ABACAVIR; AMPHOTERICIN B; ATAZANAVIR; C REACTIVE PROTEIN; CLEXIVAN; EFAVIRENZ; FLUCONAZOLE; INDINAVIR; LAMIVUDINE; LITONAVIR; LOPINAVIR; STAVUDINE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CD4+ T LYMPHOCYTE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CRYPTOCOCCAL MENINGITIS; DIABETES MELLITUS; FEMALE; FEVER; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; LIVER CIRRHOSIS; MALE; MORTALITY; PARAMETER; RECURRENT DISEASE; TERTIARY HEALTH CARE;

ADULT; AGED; COMORBIDITY; FEMALE; HIV INFECTIONS; HOSPITALS; HUMANS; MALE; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES;

EID: 79955595426     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2011.52.3.482     Document Type: Article

References (19)

1. Levitz SM. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 1991;13:1163-9.
2. Perfect JR, Casadevall A. Cryptococcosis. Infect Dis Clin North Am 2002;16:837-74.
3. Pappas PG, Perfect JR, Cloud GA, Larsen RA, Pankey GA, Lancaster DJ, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 2001;33:690-9.
4. Igel HJ, Bolande RP. Humoral defense mechanisms in cryptococcosis: substances in normal human serum, saliva, and cerebrospinal fluid affecting the growth of Cryptococcus neoformans. J Infect Dis 1996;116:75-83.
5. Diamond RD, May JE, Kane MA, Frank MM, Bennett JE. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection. J Immunol 1974;112:2260-70.
6. Jarvis JN, Harrison TS. HIV associated cryptococcal meningitis. AIDS 2007;21:2119-29.
7. Graybill JR, Sobel J, Saag M, van Der Horst C, Powderly W, Cloud G, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis 2000;30:47-54.
8. Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med 1992;326:83-9.
9. Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 2000;30:710-8.
10. Bicanic T, Harrison TS. Cryptococcal meningitis. Br Med Bull 2005;72:99-118.
11. Cox GM, Perfect JR, Cryptococcus neoformans var neoformans and gattii and Trichosporon species. In: Edward LA, editor. Topley and Wilson's Microbiology and Microbial Infections, 9th ed. London: Arnold Press: 1997.
12. Kisenge PR, Hawkins AT, Maro VP, MeHele JP, Swai NS, Mueller A, et al. Low CD4 count plus coma predicts cryptococcal meningitis in Tanzania. BMC Infect Dis 2007;7:39.
13. Tanner DC, Weinstein MP, Fedorciw B, Joho KL, Thorpe JJ, Reller L. Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol 1994;32:1680-4.
14. Crowe SM, Carlin JB, Stewart KI, Lucas CR, Hoy JF. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV infected persons. J Acquir Immune Defic Syndr 1991;4:770-6.
15. van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Disease Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med 1997;337:15-21.
16. Lortholary O, Poizat G, Zeller V, Neuville S, Boibieux A, Alvarez M, et al. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy. AIDS 2006;20:2183-91.
17. Brouwer AE, Rajanuwong A, Chierakul W, Griffin GE, Larsen RA, White NJ, et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomized trial. Lancet 2008;363:1764-7.
18. Robinson PA, Bauer M, Leal MA, Evans SG, Holtom PD, Diamond DA, et al. Early mycological treatment failure in AIDS-associated cryptococcal meningitis. Clin Infect Dis 1999;28:82-92.
19. Choi KG, Choi IS, Kim KH. A clinical study of cryptococcal infection. J Korean Neurol Assoc 1984;2:14-20.